| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2018-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102352670-B1 |
| titleOfInvention |
Anti-N3pGlu amyloid beta peptide antibodies and uses thereof |
| abstract |
Antibodies to human N3pGlu Aβ, compositions comprising such N3pGlu Aβ antibodies, and the above for the treatment of diseases characterized by deposition of Aβ, including clinical or preclinical Alzheimer's disease, Down's syndrome, and clinical or preclinical cerebral amyloid angiopathy. Methods of using the N3pGlu Aβ antibody. |
| priorityDate |
2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |